HOME
|
CONTACT
|
SITEMAP
HOME
CORPORATE
MANAGEMENT TEAM
BOARD OF DIRECTORS
CLINICAL ADVISORY BOARD
SCIENTIFIC ADVISORY
BOARD
CORPORATE GOVERNANCE
TECHNOLOGY
ABOUT STEM CELLS
TECHNOLOGY VIDEOS
PUBLICATIONS
GLOSSARY
INVESTORS
STOCK INFORMATION
FINANCIAL REPORTS
INVESTOR
COMMUNICATIONS
INDUSTRY NEWS
PUBLIC COMPANIES IN
STEM CELLS
SHAREHOLDER SERVICES
INVESTOR CONTACT
NEWS & EVENTS
PRESS RELEASES
LATEST UPDATES
EVENTS
PRESENTATIONS
LINKS
TSX - Venture:
SSS
PRESS RELEASES
LATEST UPDATES
EVENTS
PRESENTATIONS
LINKS
PRESS RELEASES
Currently Viewing:
Latest Press Releases
Press releases from 2012
Press releases from 2011
Press releases from 2010
Press releases from 2009
Press releases from 2008
Press releases from 2007
Press releases from 2006
Press releases from 2005
Press releases from 2004
Dec 13, 2011
Stem Cell Therapeutics Announces Additions to Advisory Board
Dec 07, 2011
Stem Cell Therapeutics Announces Reorganization and Management Changes
Sep 27, 2011
Stem Cell Therapeutics Corp. Investor Update
Aug 25, 2011
Stem Cell Therapeutics Corp. Announces Q2 2011 Financial Results, Election of Board of Directors and Management Appointment
Aug 18, 2011
Stem Cell Therapeutics Corp. Granted Patent Portfolio and Expand Geographic Coverage of Key Stem Cell Technologies
Jul 27, 2011
Two Patent Grants Add to Stem Cell Therapeutics Corp. Patent Portfolio and Expand Geographic Coverage of Key Stem Cell Technologies
Jul 18, 2011
Stem Cell Therapeutics Corp. Announces Dr. Calvin R. Stiller and Dr Niclas Stiernholm to Join Board of Directors
Jul 12, 2011
Stem Cell Therapeutics Corp. Announces a Traumatic Brain Injury Presentation at National Neurotrauma Symposium 2011
Jun 28, 2011
Stem Cell Therapeutics Corp. Announces the Appointment of Mr. David Allan as Executive Chairman and Dr. Henry Friesen as a Member of the Board of Directors
Jun 28, 2011
Stem Cell Therapeutics Corp. Announces Q1 2011 Financial Results
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade:
0.05
Change:
0.00%
Volume:
46300
Date:
2/3/2012
Time:
3:08pm
Note: Quotes are delayed. For informational purposes only.
LETTER TO SHAREHOLDERS
+
2011 Letter to Shareholders
©2004 - 2012 Stem Cell Therapeutics - All rights reserved
Home
|
Site Map
|
Terms Of Use
|
Contact Us